INSULET CORP (PODD)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for PODD
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| PODD | Retired President and Chief Operating Officer, Stryker Corporation; Chairman of the Board | 61 | ["Board Chair from January 2019 to December 2025","Executive Advisor at Stryker Corporation","President and Chief Operating Officer at Stryker","Group President overseeing Stryker’s MedSurg and Neurotechnology divisions","Various roles at Stryker from 1990 to 2009","Bachelor of Business Administration and a Master of Business Administration from the University of Notre Dame","Extensive strategic, organizational, and operational skills and experience"] | ["Nominating, Governance and Risk Committee","Nominating","Governance and Risk","Talent and Compensation"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| SYK | Executive Advisor | [] | [] | 2022 |
Biography sourced from the proxy statement filing.
Mr. Scannell has served on our Board of Directors since August 2014 and as our Board Chair from January 2019 to December 2025. From October 2021 to March 2023, he served as an Executive Advisor at Stryker Corporation, a leading medical technology company that offers innovative products and services in orthopaedics, medical and surgical, and neurotechnology and spine that help improve patient and hospital outcomes. From August 2018 to September 2021, he served as the President and Chief Operating Officer at Stryker, and from 2009 to August 2018, he served as a Group President overseeing Stryker s MedSurg and Neurotechnology divisions. From 1990 to 2009, Mr. Scannell served in a number of roles at Stryker, including a range of sales and marketing leadership roles, Vice President and General Manager of Stryker s Biotech division and President of Stryker s Spine business. Mr. Scannell holds a Bachelor of Business Administration and a Master of Business Administration from the University of Notre Dame. He brings extensive strategic, organizational, and operational skills and experience.